Research output per year
Research output per year
Personal profile
Research interests
My area of research is in genomics, immunotherapy and clinical trials for patients with thoracic malignancies.
Clinical interests
Medical oncology, lung cancer
Fingerprint
Dive into the research topics where Daniel Morgensztern is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies
Kang, D., Wang, Y., Lin, Y., Ma, W. W., Morgensztern, D., Leventakos, K., Bi, C., Ding, Y., Xiong, J., Yan, M., Sun, X., Wang, P., Ma, C. & Wang, Y., Jul 15 2025, In: Clinical Cancer Research. 31, 14, p. 3019-3032 14 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Non–Small Cell Lung Cancer, Version 7.2025 Featured Updates to the NCCN Guidelines
Riely, G. J., Wood, D. E., Aisner, D. L., Loo, B. W., Axtell, A. L., Bauman, J. R., Bharat, A., Chang, J. Y., Desai, A., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Juloori, A., Lackner, R. P., Lanuti, M., Levy, B. & Lin, J. & 21 others, , Sep 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 9, p. 354-362 9 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Phase i Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients with Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine Carcinomas
Wermke, M., Gambardella, V., Kuboki, Y., Felip, E., Sanmamed, M. F., Alese, O. B., Sayehli, C. M., Arriola, E., Wolf, J., Villaruz, L. C., Bertulis, J., Studeny, M., Bouzaggou, M., Fang, X. & Morgensztern, D., 2025, (Accepted/In press) In: Journal of Clinical Oncology. JCO-25-00363.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Thymomas and Thymic Carcinomas, Version 2.2025
Riely, G. J., Wood, D. E., Loo, B. W., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Chang, J. Y., Chirieac, L. R., DeCamp, M., Desai, A., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Juloori, A., Lackner, R. P. & Lanuti, M. & 22 others, , Jun 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 6, p. 255-269 15 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Toripalimab for Extensive-Stage Small Cell Lung Cancer
Cali Daylan, A. E., Morgensztern, D. & Waqar, S. N., Jan 16 2025, In: JAMA oncology. 11, 1, p. 26-27 2 p.Research output: Contribution to journal › Comment/debate